&nbsp;

CCO Clinical Trials Assessment

Mar 2024

Regimen

CRBPGEMC+DURV

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Durvalumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2024

Regimen

CISPGEMC+DURV

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Durvalumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2024

Regimen

CISPGEMC+TISL

Cancer Type:

Head and Neck,

Nasopharynx

Intent: Palliative

Drugs Used:

tislelizumab (Unfunded),

gemcitabine,

CISplatin

... Show more tags

Quick Link(s):

Regimen Monograph

Apr 2024

Document

CLAinAdultsPathwayMap.pdf

Apr 2024

Document

CLAinAdultsPathwayMapAcknowledgments.pdf

Apr 2024

Cervical Lymphadenopathy in Adults Pathway Map

Regimen

CRBPGEMC+TISL

Cancer Type:

Head and Neck,

Nasopharynx

Intent: Palliative

Drugs Used:

tislelizumab (Unfunded),

gemcitabine,

CARBOplatin

... Show more tags

Quick Link(s):

Regimen Monograph

May 2024

Regimen

CRBPGEMC+NIVL

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab - Neoadjuvant Treatment for Non-Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2024

Document

ChangestoSelfImageforGynecologicalCancerSurvivors.pdf

Jul 2024

Document